[1] Heffner JE,Nietert PJ,Barbieri C.Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions[J].Chest,2000,117(1):79-86.
[2] 周全,吴熊焰,刘炳亚,等.IL-33及其受体与肿瘤发生、发展关联性的研究进展[J].外科理论与实践,2013,18(6):581-585.
[3] Hooper CE,Lee YC,Maskell NA.Interferon-gamma release assays for the diagnosis of TB pleural effusions:hype or real hope[J].Curr Opin Pulm Med,2009,15(4):358-365.
[4] Seiscento M,Vargas FS,Acencio MM,etal.Pleural fluid cytokines correlate with tissue inflammatory expression in tuberculosis[J].Int J Tuberc Lung Dis,2010,14(9):1153-1158.
[5] Blom L,Poulsen LK.IL-1 family members IL-18 and IL-33 upregulate the inflammatory potential of differentiated human Th1 and Th2 cultures[J].J Immunol,2012,189(9):4331-4337.
[6] Masamune A,Watanabe T,Kikuta K,et al.Nuclear expression of interleukin-33 in pancreatic stellate cells[J].Am J Physiol Gastrointest Liver Physiol,2010,299(4):G821-G832.
[7] Wu YB,Ye ZJ,Qin SM,et al.Combined detections of interleukin 27,interferon-γ,and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy[J].Chin Med J,2013,126(17):3215-3221.
[8] Stathopoulos GT,Kalomenidis I.Malignant pleural effusion:tumor-host interactions unleashed[J].Am J RespirCrit Care Med,2012,186(6):487-492.
[9] Liew FY,Pitman NI,McInnes IB. Disease-associated functions of IL-33:the new kid in the IL-1 family[J]. Nat Rev Immunol,2010,10(2):103-110.
[10] Gao K,Li X,Zhang L,et al. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasisin mice[J]. Cancer Lett,2013,335(2):463-471.
[11] Villarreal DO,Wise MC,Walters JN,et al.Alarmin IL-33 acts as an immuneadjuvant to enhance antigen-specific tumor immunity[J].Cancer Res,2014,74(6):1789-1800.
[12] Guo L,Junttila IS,Paul WE.Cytokine-induced cytokine production by conventional and innate lymphoid cells[J].Trends Immunol,2012,33(12):598-606.
[13] Jovanovic IP,Pejnovic NN,Radosavljevic GD,et al. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells[J].Int J Cancer,2014,134(7):1669-1682.
[14] Yu XX,Hu Z,Shen X,et al. IL-33 promotes gastric cancer cell invasion and migration via ST2-ERK1/2 pathway[J]. Dig Dis Sci,2015,60(5):1265-1272.
[15] 邓旭,卢斌峰,蒋敬庭.IL-33及其受体ST2在抗病毒和抗肿瘤免疫应答中的意义[J].临床检验杂志,2015,33(2):130-133.
[16] 李苑博,张继红,符爽,等.IL-33在肿瘤中作用的研究进展[J].现代肿瘤医学,2016,24(5):843-847.
[17] 明浩,李翀,蒋敬庭.IL-33呼吸系统疾病中的作用机制与意义[J].现代免疫学,2015,35(5):437-440.
[18] Chen XJ,Huang YD,Li N,et al.Correlations between serum IL33 and tumor development:a meta-analysis[J].Asian Pac JCancer Prev,2014,15(8):3503-3505. |